Top Purchase Related
Home
>
Node
>
Subnode

The treatment of intermediate thalassemia

Cacciola, E.

Haematologica 74(5 Suppl): 252-265

1989

ISSN/ISBN: 0390-6078
PMID: 2480271
Document Number: 346196

Document emailed within 1 workday
Secure & encrypted payments

Viprakasit, V.; Tanphaichitr, V.S.; Mahasandana, C.; Assteerawatt, A.; Suwantol, L.; Veerakul, G.; Kankirawatana, S.; Pung-Amritt, P.; Suvatte, V. 2001: Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin e patients under different treatment regimens Journal of the Medical Association of Thailand 84(7): 929-941
Majeed, T.; Akhter, M.A.; Nayyar, U.; Riaz, M.S.; Mannan, J. 2013: Frequency of beta-thalassemia trait in families of thalassemia major patients, Lahore Journal of Ayub Medical College Abbottabad: Jamc 25(3-4): 58-60
Issaragrisil, S.; Wanachiwanawin, W.; Bhuripanyo, K.; Benjasuratwong, Y.; Piankijagum, A.; Wasi, P. 1987: Infection in thalassemia: a retrospective study of 1,018 patients with beta-thalassemia/Hb E disease Birth Defects Original Article Series 23(5a): 505-511
Jamal, R.; Baizura, J.; Hamidah, A.; Idris, N.; Jeffrey, A.H.; Roslan, H. 2005: Abnormalities in lung function among multiply-transfused thalassemia patients: results from a thalassemia center in Malaysia Southeast Asian Journal of Tropical Medicine and Public Health 36(1): 265-269
Orisaka, M.; Koyamada, K.; Suzuki, Z.; Itoh, T.; Harano, K.; Harano, T. 1998: Beta(+)-thalassemia (-31CapA-->G) homozygosity discovered on the mass medical examination: diagnosis for beta-thalassemia and DNA analysis Rinsho Byori. Japanese Journal of Clinical Pathology 46(3): 259-264
Akhundova, A.M. 1974: Clinical course and treatment of thalassemia Problemy Gematologii i Perelivaniia Krovi 19(10): 18-22
Limborskaia, S.A.; Bukhman, V.L.; Prosniak, M.I.; Fedorov, A.N.; Slominskiĭ, P.A. 1987: Molecular causes of thalassemia. IV. Cloning of the beta-globin gene in a patient with beta-thalassemia from Azerbaijan and determination of the point mutation in a minor intron Genetika 23(2): 228-238
Pranpanus, S.; Sirichotiyakul, S.; Srisupundit, K.; Tongsong, T. 2009: Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait Journal of the Medical Association of Thailand 92(6): 739-743
Tatu, T.; Sritong, W.; Sa-Nguansermsri, T. 2014: The associations of SEA-alpha thalassemia 1, XmnI-Ggamma polymorphism and beta-globin gene mutations with the clinical severity of beta-thalassemia syndrome in northern Thailand Journal of the Medical Association of Thailand 97(3): 300-307
Loukopoulos, D. 1976: Present status of treatment of thalassemia in Greece Birth Defects Original Article Series 12(8): 1-11
Indrák, K.; Divoký, V.; Brabec, V.; Chrobák, L.; Mociková, K.; Sakalová, A.; Svobodová, M.; Indráková, J.; Hammerová, T.; Zarnovicanová, M. 1994: Dominant beta-thalassemia alleles in the Czech and Slovak population (beta-thalassemia mutations in 112(T-A) and 121(G-T) codons and the unstable Hradec Králové hemoglobin or alpha 2 beta 2 115 (G17) Ala-Asp) Vnitrni Lekarstvi 40(4): 223-230
Iwanaga, T.; Furukawa, H.; Hiratsuka, M. 1986: Surgical treatment of intermediate-stage gastric cancer Gan no Rinsho. Japan Journal of Cancer Clinics 32(10): 1195-1202
Sánchez-Tejero, Eías.; García-Sánchez, E. 2004: Empirical treatment with doxycycline for fever of intermediate duration? Enfermedades Infecciosas y Microbiologia Clinica 22(6): 365; Author Reply 365-6
Maspes, V.; Tamigaki, M.; Gabriel, E.A.; Moita, P.R.; Jamra, M. 1970: Use of deferoxamine-B (Desferal) in the treatment of secondary hemosiderosis in thalassemia major Sangre 15(4): 435-443
Issaragrisil, S.; Piankigagum, A.; Wasi, P. 1981: Spinal cord compression in thalassemia. Report of 12 cases and recommendations for treatment Archives of Internal Medicine 141(8): 1033-1036
Shi, X.-f.; Zhang, Y.; Liu, N. 2009: Clinical observation on blood perfusion for treatment of organophosphorus poisoning intermediate syndrome Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 27(5): 303-304
Lu, W.-x. 2012: Identifying intermediate risk acute pulmonary thromboembolism patients and their treatment strategies Zhonghua Yi Xue Za Zhi 92(26): 1804-1806
Cvek, J.; Feltl, D.; Hajek, J.; Jackaninova, J.; Ruzickova, K.; Havranek, O.; Dvorackova, J.; Dobes, P. 2014: Is there an intermediate-risk non-seminoma? long-term treatment results from a single center Journal of BUON: Official Journal of the Balkan Union of Oncology 19(3): 775-779
Di Marco, V.; Lo Iacono, O.; Capra, M.; Grutta, S.; Ciaccio, C.; Gerardi, C.; Maggio, A.; Renda, D.; Almasio, P.; Pisa, R. 1992: alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia Haematologica 77(6): 502-506
Ermakova, N.A. 2002: Preference for transscleral cryocoagulation of peripheral exudate in intermediate ubitis before traditional methods of treatment Vestnik Oftalmologii 118(6): 29-31